Molecular fingerprinting in human lung cancer

Clinical Lung Cancer

Volumn 5, Issue 2, 2003, Pages 113-118

  Yanagisawa, Kiyoshi ^a   Xu, Baogang J ^b   Carbone, David P ^a   Caprioli, Richard M ^b  

^a VANDERBILT INGRAM CANCER CENTER   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Mass spectrometry; Microarray; Proliferating cell nuclear antigen; Proteomics; Thyroid transcription factor; Vascular endothelial growth factor

Indexed keywords

ACID PROTEINASE; ADENOSINE TRIPHOSPHATE; ANTINEOPLASTIC AGENT; ANTIOXIDANT; BIOLOGICAL MARKER; CATHEPSIN D; COMPLEMENTARY DNA; CYCLINE; CYTOKERATIN; DNA; GLUTATHIONE TRANSFERASE; MESSENGER RNA; MOLECULAR MARKER; PROTEIN DISULFIDE ISOMERASE; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE; RIBONUCLEOPROTEIN; RNA;

BIOMEDICINE; CANCER CHEMOTHERAPY; CANCER CLASSIFICATION; CANCER RECURRENCE; CANCER TISSUE; CELL TYPE; CLINICAL PRACTICE; DNA FINGERPRINTING; DNA MICROARRAY; DRUG RESPONSE; GENE EXPRESSION PROFILING; GENE TECHNOLOGY; GENOME ANALYSIS; HEALTH SURVEY; HISTOPATHOLOGY; HUMAN; LUNG NON SMALL CELL CANCER; MASS SPECTROMETRY; MATHEMATICAL ANALYSIS; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MOLECULAR MECHANICS; PREDICTION; PROGNOSIS; PROTEIN EXPRESSION; PROTEOMICS; REVIEW; STANDARDIZATION; TUMOR DIFFERENTIATION; TWO DIMENSIONAL GEL ELECTROPHORESIS;

EID: 0242320428     PISSN: 15257304     EISSN: None     Source Type: Journal    
DOI: 10.3816/CLC.2003.n.025     Document Type: Article

References (37)

1. Jemal A, Murray T, Samuels A, et al. Cancer statistics, 2003. CA Cancer J Clin 2003; 53:5-26.
2. Carbone DP. The biology of lung cancer. Semin Oncol 1997; 24:388-401.
3. Minna JD. Neoplasms of the lung. In: Braunwalk E, Fauci A, Isselbacher K, et al, ed. Harrison's Principles of Internal Medicine. New York: McGraw-Hill, 2001:562-571.
4. Beer DG, Kardia SL, Huang CC, et al. Gene-expression profiles predict survival of patients with lung adenocarcinoma. Nat Med 2002; 8:816-824.
5. Bhattacharjee A, Richards WG, Staunton J, et al. Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses. Proc Natl Acad Sci USA 2001; 98:13790-13795.
6. Garber ME, Troyanskaya OG, Schluens K, et al. Diversity of gene expression in adenocarcinoma of the lung. Proc Natl Acad Sci USA 2001; 98:13784-13789.
7. Golub TR, Slonim DK, Tamayo P, et al. Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science 1999; 286:531-537.
8. Anderson L, Seilhamer J. A comparison of selected mRNA and protein abundances in human liver. Electrophoresis 1997; 18:533-537.
9. Wilkins MR, Sanchez JC, Williams KL, et al. Current challenges and future applications for protein maps and post-translational vector maps in proteome projects. Electrophoresis 1996; 17:830-838.
10. Chen G, Gharib TG, Huang CC, et al. Discordant protein and mRNA expression in lung adenocarcinomas. Mol Cell Proteomics 2002; 1:304-313.
11. Pandey A, Mann M. Proteomics to study genes and genomes. Nature 2000; 405:837-846.
12. Banks RE, Dunn MJ, Hochstrasser DF, et al. Proteomics: new perspectives, new biomedical opportunities. Lancet 2000; 356:1749-1756.
13. Wright GL Jr. Two-dimensional acrylamide gel electrophoresis of cancer-patient serum proteins. Ann Clin Lab Sci 1974; 4:281-293.
14. Chen G, Gharib TG, Huang CC, et al. Proteomic analysis of lung adenocarcinoma: identification of a highly expressed set of proteins in tumors. Clin Cancer Res 2002; 8:2298-2305.
15. Hanash S, Brichory F, Beer D. A proteomic approach to the identification of lung cancer markers. Dis Markers 2001; 17:295-300.
16. Oh JM, Brichory F, Puravs E, et al. A database of protein expression in lung cancer. Proteomics 2001; 1:1303-1319.
17. Brichory F, Beer D, Le Naour F, et al. Proteomics-based identification of protein gene product 9.5 as a tumor antigen that induces a humoral immune response in lung cancer. Cancer Res 2001; 61:7908-7912.
18. Bergman AC, Benjamin T, Alaiya A, et al. Identification of gel-separated tumor marker proteins by mass spectrometry. Electrophoresis 2000; 21:679-686.
19. Hirano T, Franzen B, Uryu K, et al. Detection of polypeptides associated with the histopathological differentiation of primary lung carcinoma. Br J Cancer 1995; 72:840-848.
20. Hirano T, Fujioka K, Franzen B, et al. Relationship between TA01 and TA02 polypeptides associated with lung adenocarcinoma and histocytological features. Br J Cancer 1997; 75:978-985.
21. Schmid HR, Schmitter D, Blum P et al. Lung tumor cells: a multivariate approach to cell classification using two-dimensional protein pattern. Electrophoresis 1995; 16:1961-1968.
22. Okuzawa K, Franzen B, Lindholm J, et al. Characterization of gene expression in clinical lung cancer materials by two-dimensional polyacrylamide get electrophoresis. Electrophoresis 1994; 15:382-390.
23. Gharib TG, Chen G, Wang H, et al. Proteomic analysis of cytokeratin isoforms uncovers association with survival in lung adenocarcinoma. Neoplasia 2002; 4:440-448.
24. Petricoin EF III, Ornstein DK Paweletz CP, et al. Serum proteomic patterns for detection of prostate cancer. J Natl Cancer Inst 2002; 94:1576-1578.
25. Ardekani AM, Liotta LA, Petricoin EF III. Clinical potential of proteomics in the diagnosis of ovarian cancer. Expert Rev Mol Diagn 2002; 2:312-320.
26. Adam BL, Qu Y, Davis JW, et al. Serum protein fingerprinting coupled with a pattern-matching algorithm distinguishes prostate cancer from benign prostate hyperplasia and healthy men. Cancer Res 2002; 62:3609-3614.
27. Li J, Zhang Z, Rosenzweig J, et al. Proteomics and bioinformatics approaches for identification of serum biomarkers to detect breast cancer. Clin Chem 2002; 48:1296-1304.
28. Petricoin EF, Ardekani AM, Hitt BA, et al. Use of proteomic patterns in serum to identify ovarian cancer. Lancet 2002; 359:572-577.
29. Poon TC, Yip TT, Chan AT, et al. Comprehensive proteomic profiling identifies serum proteomic signatures for detection of hepatocellular carcinoma and its subtypes. Clin Chem 2003; 49:752-760.
30. Caprioli RM, Farmer TB, Gile J. Molecular imaging of biological samples: localization of peptides and proteins using MALDI-TOF MS. Anal Chem 1997; 69:4751-4760.
31. Chaurand F, DaGue BB, Pearsall RS, et al. Profiling proteins from azoxymethane-induced colon tumors at the molecular level by matrix-assisted laser desorption/ionization mass spectrometry. Proteomics 2001; 1:1320-1326.
32. Chaurand F, Schwartz SA, Caprioli RM. Imaging mass spectrometry: a new tool to investigate the spatial organization of peptides and proteins in mammalian tissue sections. Curr Opin Chem Biol 2002; 6:676-681.
33. Stoeckli M, Chaurand P, Hallahan DE, et al. Imaging mass spectrometry: a new technology for the analysis of protein expression in mammalian tissues. Nat Med 2001; 7:493-496.
34. Walter G, Bussow K, Cahill D, et al. Protein arrays for gene expression and molecular interaction screening. Curr Opin Microbiol 2000; 3:298-302.
35. Uetz P. Giot L, Cagney G, et al. A comprehensive analysis of protein-protein interactions in Saccharomyces cerevisiae. Nature 2000; 403:623-627.
36. Griffiths AD, Duncan AR. Strategies for selection of antibodies by phage display. Curr Opin Biotechnol 1998; 9:102-108.
37. McKerrow JH, Bhargava V, Hansell E, et al. A functional proteomics screen of proteases in colorectal carcinoma. Mol Med 2000; 6:450-460.